查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1867003

裸金属支架市场按类型、材料、应用、最终用户和长度划分－2025-2032年全球预测

Bare-metal Stents Market by Type, Material, Application, End User, Length - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，裸金属支架市场将成长至 103.7 亿美元，复合年增长率为 5.85%。

主要市场统计数据
基准年 2024 65.7亿美元
预计年份：2025年 69.6亿美元
预测年份：2032年 103.7亿美元
复合年增长率 (%) 5.85%

裸金属支架的权威说明，重点介绍其在现代介入医学中的临床作用、材料演变和手术重要性。

裸金属支架是血管介入治疗的基础组成部分，其器械选择、手术操作和材料科学均对患者预后产生影响。本文回顾了目前的技术和临床现状，并阐述了裸金属支架在特定患者群体和手术场景中的持续作用。儘管药物释放型支架和生物可吸收支架为许多临床医生提供了新的选择，但在特定病变特征、抗凝血治疗考虑或成本或手术入路限制等情况下，裸金属支架仍然至关重要。

不断增长的临床证据、更严格的监管和价值主导型采购如何重塑裸金属支架相关人员的产品策略和竞争差异化

由于临床、技术和政策因素的共同作用，裸金属支架领域正经历变革性的变化，重新定义了竞争定位和产品研发重点。在临床方面，随着越来越多的证据出现，区分哪些患者群体可能从裸金属支架而非其他支架中获益，患者选择标准也日益精准。这促使针对特定适应症的器械设计进行调整。在技​​术方面，诸如改进合金成分、支架结构和输送系统等渐进式创新，提高了支架的输送性能并降低了急性血管损伤，从而影响临床医生的选择和手术流程。

2025 年美国关税对整个医疗设备生态系统产生了营运和策略影响，迫使企业重组供应链、实现采购多元化并重新确定采购优先顺序。

2025年关税政策的变化为跨境采购心血管器械的製造商、经销商和医疗系统带来了独特的营运和策略考量。由于各机构需要重新评估其供应商组合以控製到岸成本并降低关税波动风险，供应链设计和采购决策受到了直接影响。这种调整促使企业在短期内采取了一些行动，例如製造地多元化、增加区域库存缓衝以及加快对具备相容品质系统的替代供应商进行资格认证。

深度分割分析揭示了器材类型、材料成分、解剖应用部位、临床环境和支架长度如何共同驱动差异化的临床和商业策略。

关键的细分洞察揭示了裸金属支架领域内需求驱动因素和临床决策的多样性，为产品定位和临床互动策略提供了系统性的基础。在所有器械类型中，球囊扩张式和自扩张式平台之间的差异仍然是手术选择的核心。在冠状动脉中，需要精准的植入，因此球囊扩张式系统更受青睐；而在迂曲的外周血管中，持续的向外力和良好的贴合性至关重要，因此自扩张式设计更胜一筹。这种差异会影响研发重点和销售培训，因为不同的临床团队会优先考虑植入机制和病变特异性结果。

美洲、欧洲、中东和非洲以及亚太地区在管理体制、采购重点和临床基础设施方面的差异，决定了其商业化和市场准入策略的差异化。

区域洞察揭示了美洲、欧洲、中东和非洲以及亚太地区在医疗器材的采纳和商业化策略方面存在的差异，包括不同的需求模式、法规环境以及医疗保健系统优先事项。在美洲，医疗保健系统日益关注在保持临床品质的同时兼顾成本效益的解决方案，并优先考虑基于结果的采购。这种环境有利于以证据为基础的产品声明，并强调包含培训和结果报告的伙伴关係模式，以在不同的医院系统中展现产品价值。特定国家的报销机制和集中筹资策略进一步影响医疗设备采纳的速度和范围，因此需要製定细緻入微的市场进入计画。

竞争的驱动力在于卓越的产品设计、有针对性的临床证据收集以及将产品和服务范围从硬体扩展到整合服务解决方案的策略伙伴关係。

裸金属支架市场的竞争格局呈现出成熟医疗设备公司和专注于渐进式创新、临床证据累积和策略伙伴关係的专业厂商并存的局面。主要企业致力于打造耐用的产品设计、完善的医生培训项目以及健全的上市后监测倡议，以维护临床医生的信任并巩固基于销售的采购关係。这些企业通常会利用现有的临床资料集和多中心註册研究来展示产品在不同病变类型和患者亚群的表现。

製造商面临的切实可行的策略挑战是：如何将临床证据、产品工程和敏捷供应链结合，以确保产品应用并保持竞争优势。

产业领导者应采取多维度策略，整合产品创新、临床证据产生和商业性可行的供应链设计。首先，优先进行针对特定适应症的临床研究和註册研究，以检验产品疗效，尤其是在冠状动脉疾病亚组（如心肌梗塞和稳定性心绞痛）以及外周血管疾病（如膝下和股腘动脉）方面，这有助于在介入医师和支付方中建立差异化的信誉。这些实证研究活动应旨在解答临床医师面临的特定手术问题，并与医疗系统结果和成本效益报告要求保持一致。

我们采用严谨的混合方法调查方法，结合临床文献回顾、监管分析和专家访谈，为决策者提供检验的、可操作的见解。

本研究采用多方面方法，结合了对同行评审的临床文献的系统性回顾、监管披露资讯的分析以及对关键行业专家、采购专业人员和供应链高管的定性访谈。关键的定性研究结果与设备层面的性能数据和材料科学文献相结合，从而全面了解临床效用、设计权衡和部署环境。辅助资料来源包括临床指南、手术註册资料和公开的监管文件，并对这些资料进行交叉验证，以检验医疗设备的分类和使用趋势。

总之，该总结强调了裸金属支架的持续临床意义，以及在不断变化的临床、监管和政策压力下，为维持其应用所需的策略重点。

总之，裸金属支架在血管介入治疗领域仍然占据着重要的战略地位，其临床适应症、材料和设计方面的权衡取舍以及日益复杂的采购动态都使其备受关注。儘管其他支架材料正在拓展治疗选择，但当病变特征、抗凝血需求或入路限制使其成为首选方案时，裸金属支架仍具有显着的临床和经济价值。要在此领域取得成功，需要采取协作方式，整合针对性的临床证据、设计优化和供应链韧性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大生物可吸收金属合金的使用范围，以提高生物相容性（用于裸金属支架）
  • 新兴市场医疗预算紧张，推动了对经济实惠的裸金属支架的需求。
  • 人们对生物功能表面修饰的兴趣日益浓厚：旨在促进裸金属支架上内皮细胞的生长
  • 表面纹理化技术的进步降低了不锈钢裸金属支架的血栓形成性
  • 将即时影像相容性整合到裸金属支架中，以支援微创介入手术
  • 扩大介入心臟科专家的训练项目，以优化裸金属支架植入术的效果
  • 按地区分類的钴铬合金和不銹钢裸金属支架平台监管核准趋势
  • 透过支架製造商与诊断影像公司之间的合作，加强裸金属支架领域的产品差异化。
  • 利用3D列印技术实现裸金属支架的个人化尺寸定制，以应对复杂病变解剖结构
  • 裸金属支架分销包装和灭菌过程中註重环境永续性

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 裸金属支架市场（按类型划分）

  • 气球膨胀类型
  • 自我吹嘘

9. 按材料分類的裸金属支架市场

  • 钴铬
  • 防锈的

第十章 按应用分類的裸金属支架市场

  • 心血管系统
    • 冠状动脉
      • 心肌梗塞
      • 稳定性心绞痛
    • 结构性心臟病
  • 週边血管
    • 膝盖以下
    • 股腘动脉

第十一章 以最终用户分類的裸金属支架市场

  • 门诊手术中心
  • 医院
    • 二级护理
    • 三级医疗
  • 专科诊所
    • 心臟中心
    • 放射中心

第十二章 依长度分類的裸金属支架市场

  • 15～30
  • 超过30
  • 15人或以下

第十三章 裸金属支架市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 裸金属支架市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国裸金属支架市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • Terumo Corporation
    • Cordis Corporation
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • MicroPort Scientific Corporation
    • Merit Medical Systems, Inc.
Product Code: MRR-CD5A9334DAB9

The Bare-metal Stents Market is projected to grow by USD 10.37 billion at a CAGR of 5.85% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.57 billion
Estimated Year [2025] USD 6.96 billion
Forecast Year [2032] USD 10.37 billion
CAGR (%) 5.85%

An authoritative orientation to bare-metal stents that clarifies their clinical role, material evolution, and procedural relevance within contemporary interventional practice

The bare-metal stent landscape represents a foundational element of interventional vascular care, where device selection, procedural practice, and material science converge to affect patient outcomes. This introduction frames the current technological and clinical backdrop, situating bare-metal stents within their enduring role for specific patient cohorts and procedural contexts. While drug-eluting platforms and bioresorbable scaffolds have reshaped choices for many clinicians, bare-metal devices remain integral where specific lesion characteristics, anticoagulation considerations, or cost and access constraints dictate their use.

In discussing the device class, it is important to highlight advances in radial strength, strut geometry, and delivery system ergonomics that continue to refine procedural success and reduce complication rates. Parallel progress in imaging, such as intravascular ultrasound and optical coherence tomography, enhances lesion assessment and device placement precision, thereby increasing the clinical value delivered by contemporary bare-metal stents. Moreover, material improvements in cobalt chromium and stainless steel alloys have created a spectrum of options that balance visibility, flexibility, and chronic vessel interaction.

Regulatory pathways and clinical evidence generation remain crucial drivers of adoption, with randomized studies and registries informing guidelines and reimbursement decisions. The intersection of clinical need, device evolution, and health system economics sets the stage for stakeholders to make evidence-based decisions. This report opens by establishing these core themes and prepares readers for a deeper analysis of market dynamics, policy impacts, segmentation insights, and regional variations that collectively shape strategic imperatives for manufacturers, clinicians, and payers.

How converging clinical evidence, regulatory stringency, and value-driven procurement are reshaping product strategies and competitive differentiation for bare-metal stent stakeholders

The bare-metal stent domain is undergoing transformative shifts driven by converging clinical, technological, and policy forces that are redefining competitive positioning and product development priorities. Clinically, patient selection is becoming more nuanced as evidence distinguishes subpopulations that benefit from bare-metal solutions versus alternative scaffolds, prompting a recalibration of indication-specific device design. Technologically, incremental innovations in alloy formulation, strut architecture, and delivery system refinement are enabling improved deliverability and reduced acute vessel trauma, which in turn inform clinician preference and procedural workflow.

Simultaneously, health systems are intensifying scrutiny of total procedural value, factoring in device cost, hospitalization duration, and post-procedural care needs. As a result, procurement decisions are increasingly influenced by comparative performance metrics and real-world evidence rather than price alone. Regulatory landscapes are evolving as well, with more rigorous post-market surveillance expectations and demand for longitudinal safety data that can alter life-cycle management strategies for existing platforms. These regulatory dynamics incentivize manufacturers to invest in extended follow-up studies and registry partnerships to sustain clinician and payer confidence.

Innovation ecosystems are further shaped by the integration of digital health tools, such as procedural analytics and remote follow-up platforms, that extend the value proposition of device manufacturers beyond hardware. Collaborations between device firms and service providers are emerging to bundle devices with analytics, training, and outcomes reporting, creating differentiated offerings that address both clinical and economic stakeholder needs. Together, these shifts underscore a market in which incremental technical advances intersect with broader system-level priorities, compelling firms to adopt a more holistic, evidence-driven approach to product strategy and commercialization.

Operational and strategic consequences of U.S. tariff measures in 2025 that compelled supply chain reconfiguration, sourcing diversification, and procurement reprioritization across the device ecosystem

Tariff policy changes in the United States during 2025 introduced a distinct set of operational and strategic considerations for manufacturers, distributors, and health systems that engage in cross-border procurement of cardiovascular devices. Supply chain design and sourcing decisions were directly affected as organizations re-evaluated supplier portfolios to manage landed costs and mitigate exposure to tariff volatility. This realignment prompted near-term shifts toward diversifying manufacturing footprints, increasing regional inventory buffers, and accelerating qualification of alternative suppliers with compatible quality systems.

Procurement teams reacted by intensifying contract negotiations, seeking longer-term agreements that could stabilize inbound pricing and reduce transactional uncertainty. At the same time, some firms revisited their value engineering initiatives to offset cost impacts without compromising clinical performance, focusing on material selection, manufacturing efficiencies, and packaging optimization. For device companies with vertically integrated production, accelerated capital allocation toward domestic or tariff-exempt manufacturing nodes became a tactical lever to preserve market access and protect margins.

Clinically, hospitals and ambulatory surgical centers confronted procurement trade-offs where device selection decisions had to balance immediate budgetary constraints against longer-term clinical outcomes and reintervention risks. The tariff environment also influenced investor sentiment and strategic partnerships, with cross-border joint ventures and licensing arrangements emerging as mechanisms to maintain market presence while sharing the burden of localized manufacturing and regulatory compliance. Collectively, these dynamics emphasize the importance of flexible supply chain strategies, proactive regulatory planning, and commercially defensible pricing models in a landscape altered by tariff interventions.

Deep segmentation analysis revealing how device type, material composition, anatomical application, clinical setting, and stent length combine to drive differentiated clinical and commercial strategies

Key segmentation insights illuminate the heterogeneity of demand drivers and clinical decision-making within the bare-metal stent category, providing a structured basis for product positioning and clinical engagement strategies. Across device type, the dichotomy between balloon expandable and self-expanding platforms remains central to procedural selection, with balloon expandable systems favored for precise deployment in coronary settings and self-expanding designs offering advantages in tortuous or peripheral vessels where chronic outward force and conformability are paramount. This distinction influences R&D prioritization and sales training as different clinical teams emphasize deployment mechanics and lesion-specific outcomes.

Material segmentation further differentiates product attributes, with cobalt chromium alloys offering superior radial strength and radiopacity relative to stainless steel, which in turn yields trade-offs in flexibility and cost. Product teams must therefore align material choices to targeted lesion subsets and clinician preferences, ensuring that bench performance translates into predictable clinical behavior. Application-based segmentation clarifies end-use contexts: cardiovascular applications encompass coronary and structural heart interventions, where the coronary subdomain addresses acute conditions such as myocardial infarction and stable angina with distinct procedural imperatives, while peripheral vascular use includes below-the-knee and femoropopliteal territories that present unique lesion morphology and durability considerations. These clinical nuances necessitate tailored evidence packages and targeted physician education that speak directly to differential outcomes across anatomical locations.

End-user segmentation highlights variations across ambulatory surgical centers, hospitals, and specialty clinics. Hospitals bifurcate into secondary care and tertiary care settings, each with different case mixes, procurement processes, and clinical governance that influence device adoption timelines. Specialty clinics such as dedicated cardiac centers and radiology centers require customized supply relationships and training models to integrate devices into their specific workflows. Length-based segmentation-devices designed for lengths less than 15 millimeters, within a 15 to 30 millimeter range, or greater than 30 millimeters-further refines product portfolios, as lesion length correlates with procedural complexity, overlap strategies, and adjunctive therapy choices. Synthesizing these segmentation layers enables commercial teams to position product variants with precision, tailor clinical evidence generation, and design pricing strategies that reflect clinical utility and procedural economics.

How contrasting regulatory regimes, procurement priorities, and clinical infrastructure across the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated commercialization and access strategies

Regional insights reveal divergent demand patterns, regulatory environments, and health system priorities that shape adoption and commercialization approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories. In the Americas, health systems emphasize outcome-driven procurement with an increasing focus on cost-effective solutions that preserve clinical quality; this context favors evidence-backed product claims and emphasizes partnership models that include training and outcomes reporting to demonstrate value across diverse hospital systems. Reimbursement mechanisms and centralized procurement strategies in certain countries further influence the pace and scope of device uptake, requiring nuanced market access planning.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and localized health economics assessments create a layered commercialization landscape. Countries within this region vary widely in their procedural volumes, infrastructure maturity, and reimbursement frameworks, which necessitates flexible go-to-market models that can be adapted to both high-acuity tertiary centers and emerging secondary care facilities. In many markets, clinician networks and regional opinion leaders play an outsized role in adoption, making targeted clinical partnerships and registry participation critical.

The Asia-Pacific region exhibits dynamic growth in interventional capacity, with a broad spectrum of clinical settings from high-volume centers in advanced economies to rapidly developing hospital infrastructures elsewhere. Supply chain logistics, tariff considerations, and local manufacturing partnerships are particularly salient here, as device accessibility often depends on regulatory alignment and strategic in-region production. Across all regions, tailoring clinical evidence, training programs, and commercial propositions to the specific procurement drivers and care delivery models is essential to unlocking sustainable adoption and building long-term clinician trust.

Competitive dynamics driven by product engineering excellence, targeted clinical evidence collection, and strategic partnerships that extend offerings beyond hardware into integrated service solutions

The competitive landscape for bare-metal stents is characterized by a mix of established medical device firms and specialized companies that prioritize incremental innovation, clinical evidence generation, and strategic partnerships. Leading organizations invest in durable product engineering, comprehensive physician training programs, and robust post-market surveillance initiatives to maintain clinician confidence and support volume-based procurement relationships. These firms often leverage legacy clinical datasets and multi-center registries to demonstrate device performance across varied lesion types and patient subgroups.

At the same time, smaller and mid-sized companies focus on niche differentiation through novel alloy formulations, unique strut designs, or specialized delivery systems that address specific anatomical challenges or procedural workflows. Collaboration between such innovators and larger distributors or contract manufacturers accelerates market entry while mitigating scale-related constraints. Partnerships with clinical investigators and hospital networks enable rapid collection of real-world evidence that can substantiate claims and inform iterative design improvements.

Strategic alliances extend beyond product development, encompassing logistics providers, analytics vendors, and training organizations to create integrated offerings that extend the value proposition to hospitals and clinics. Companies that align research priorities with payer evidence requirements and procedural economics are better positioned to influence procurement decisions. Overall, competitive success hinges on a combination of engineering excellence, evidence-based engagement, and flexible commercial models that respond to evolving clinician and health system expectations.

Actionable strategic imperatives for manufacturers to align clinical evidence, product engineering, and agile supply chains to secure adoption and sustain competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with clinical evidence generation and commercially pragmatic supply chain design. First, prioritizing targeted clinical studies and registries that address indication-specific performance-particularly in coronary subsets such as myocardial infarction and stable angina as well as peripheral territories like below-the-knee and femoropopliteal-will create differentiated credibility among interventionists and payers. These evidence efforts should be designed to answer the specific procedural questions that clinicians face, and to dovetail with health system requirements for outcomes and cost-effectiveness reporting.

Second, manufacturers should pursue material and design investments that map to clear clinical advantages; for example, alloy selection between cobalt chromium and stainless steel should be justified by demonstrable benefits in deliverability, radiopacity, or strut performance for the targeted lesion set. Concurrently, modular product portfolios organized by stent length categories and deployment mechanism-balloon expandable versus self-expanding-enable more precise matching of device attributes to lesion morphology, reducing off-label use and optimizing clinical outcomes.

Third, rethinking supply chain architecture to incorporate regional manufacturing, inventory flexibility, and tariff-aware sourcing will mitigate geopolitical and policy risks. Complementary commercial initiatives should bundle training, procedural analytics, and post-market surveillance to create a total product offering valued by hospitals and specialty clinics. Finally, adopt flexible pricing and contracting models that reflect the procurement realities of ambulatory surgical centers, secondary and tertiary hospitals, and specialty clinics, thereby improving access while protecting margin and supporting sustained innovation.

A rigorous mixed-method research framework combining clinical literature review, regulatory analysis, and expert interviews to produce a validated and actionable synthesis for decision-makers

This research employed a multi-method approach combining systematic review of peer-reviewed clinical literature, analysis of regulatory public records, and qualitative interviews with key opinion leaders, procurement specialists, and supply chain executives. Primary qualitative insights were synthesized with device-level performance data and material science literature to create an integrated view of clinical utility, design trade-offs, and deployment contexts. Secondary sources included clinical guidelines, procedural registries, and publicly available regulatory documents, which were cross-referenced to validate device classifications and usage trends.

Interview subjects were selected to represent a balanced cross-section of interventionists, hospital procurement leaders, and device development professionals across varied geographies and clinical settings. The synthesis prioritized triangulation of findings, aligning clinician perspectives with documented outcomes and regulatory milestones to reduce bias and improve applicability. Methodological rigor was maintained through transparent documentation of inclusion criteria, source provenance, and the analytical framework used to map segmentation, regional dynamics, and competitive positioning.

Limitations inherent to this approach include variability in reporting standards across registries, differential availability of long-term post-market data, and rapid evolution in device development that may outpace published literature. To mitigate these constraints, the research emphasizes evidence-weighting and signals derived from recent high-quality sources and expert consensus, while recommending ongoing surveillance of emerging data to refine strategic decisions.

Concluding synthesis emphasizing the enduring clinical relevance of bare-metal stents and the strategic priorities required to maintain adoption amid evolving clinical, regulatory, and policy pressures

In conclusion, the bare-metal stent domain remains strategically important within interventional vascular care, defined by nuanced clinical indications, material and design trade-offs, and increasingly sophisticated procurement dynamics. While alternative scaffolds have expanded therapeutic options, bare-metal devices continue to offer distinct clinical and economic value where lesion characteristics, anticoagulation needs, or access constraints make them the preferred choice. Success in this landscape requires a coordinated approach that integrates targeted clinical evidence, design optimization, and supply chain resilience.

Manufacturers and stakeholders that align product portfolios to clinically meaningful segmentation-encompassing device type, material composition, application area, end-user context, and stent length-will be best positioned to address clinician needs and procurement realities. Regional strategies must be adapted to local regulatory frameworks and health system priorities, with particular attention to the differing dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific. Finally, tariff and policy fluctuations underscore the imperative for flexible sourcing strategies and collaborative relationships with health systems to maintain stable access.

These conclusions point toward practical next steps: invest in indication-specific evidence generation, refine material and design choices based on clinical needs, and build commercialization models that pair devices with services and data to demonstrate tangible procedural and economic value. Executed well, these measures will enable stakeholders to navigate evolving clinical expectations and policy environments while maintaining the clinical relevance of bare-metal stent platforms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of biodegradable metal alloys for enhanced vascular compatibility in bare-metal stents
  • 5.2. Growing demand for cost-effective bare-metal stents in emerging markets driven by healthcare budget constraints
  • 5.3. Rising focus on biofunctional surface modifications to improve endothelial cell growth on bare-metal stents
  • 5.4. Advances in surface texturing technologies to reduce thrombogenicity in stainless steel bare-metal stents
  • 5.5. Integration of real-time imaging compatibility features in bare-metal stents to support minimally invasive interventions
  • 5.6. Expansion of training programs for interventional cardiologists to optimize bare-metal stent implantation outcomes
  • 5.7. Regulatory approval trends for cobalt-chromium versus stainless steel bare-metal stent platforms across regions
  • 5.8. Partnerships between stent manufacturers and diagnostic imaging firms to enhance product differentiation in the bare-metal segment
  • 5.9. Shift towards personalized stent sizing and design enabled by three-dimensional printing for complex lesion anatomies with bare-metal scaffolds
  • 5.10. Emphasis on environmental sustainability in packaging and sterilization processes for bare-metal stent distribution

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bare-metal Stents Market, by Type

  • 8.1. Balloon Expandable
  • 8.2. Self Expanding

9. Bare-metal Stents Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Stainless Steel

10. Bare-metal Stents Market, by Application

  • 10.1. Cardiovascular
    • 10.1.1. Coronary
      • 10.1.1.1. Myocardial Infarction
      • 10.1.1.2. Stable Angina
    • 10.1.2. Structural Heart
  • 10.2. Peripheral Vascular
    • 10.2.1. Below The Knee
    • 10.2.2. Femoropopliteal

11. Bare-metal Stents Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospital
    • 11.2.1. Secondary Care
    • 11.2.2. Tertiary Care
  • 11.3. Specialty Clinic
    • 11.3.1. Cardiac Center
    • 11.3.2. Radiology Center

12. Bare-metal Stents Market, by Length

  • 12.1. 15 to 30
  • 12.2. Greater Than 30
  • 12.3. Less Than 15

13. Bare-metal Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bare-metal Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bare-metal Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Boston Scientific Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. Terumo Corporation
    • 16.3.5. Cordis Corporation
    • 16.3.6. B. Braun Melsungen AG
    • 16.3.7. Biosensors International Group, Ltd.
    • 16.3.8. Lepu Medical Technology (Beijing) Co., Ltd.
    • 16.3.9. MicroPort Scientific Corporation
    • 16.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BARE-METAL STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BARE-METAL STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BARE-METAL STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. AS